4.00
price up icon8.11%   0.30
after-market アフターアワーズ: 3.98 -0.02 -0.50%
loading
前日終値:
$3.70
開ける:
$3.7
24時間の取引高:
666.06K
Relative Volume:
0.58
時価総額:
$254.25M
収益:
$157.08M
当期純損益:
$-70.36M
株価収益率:
-3.5984
EPS:
-1.1116
ネットキャッシュフロー:
$-71.69M
1週間 パフォーマンス:
-7.41%
1か月 パフォーマンス:
-16.84%
6か月 パフォーマンス:
+117.39%
1年 パフォーマンス:
+133.92%
1日の値動き範囲:
Value
$3.70
$4.045
1週間の範囲:
Value
$3.36
$4.61
52週間の値動き範囲:
Value
$1.29
$5.08

Macrogenics Inc Stock (MGNX) Company Profile

Name
名前
Macrogenics Inc
Name
セクター
Healthcare (1074)
Name
電話
301-251-5172
Name
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
Name
職員
293
Name
Twitter
@macrogenics
Name
次回の収益日
2026-08-13
Name
最新のSEC提出書
Name
MGNX's Discussions on Twitter

Compare MGNX vs VRTX, REGN, ARGX, RVMD, ALNY

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
MGNX icon
MGNX
Macrogenics Inc
4.00 235.18M 157.08M -70.36M -71.69M -1.1116
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
479.00 121.16B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
667.17 68.78B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
888.82 57.44B 4.16B 1.29B 734.26M 19.58
RVMD icon
RVMD
Revolution Medicines Inc
188.07 40.23B 742.00K -1.37B -1.07B -7.0731
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
278.40 36.28B 4.29B 577.22M 641.34M 4.2086

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 アップグレード B. Riley Securities Neutral → Buy
2025-09-17 再開されました Barclays Overweight
2024-11-07 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2024-08-01 ダウングレード BTIG Research Buy → Neutral
2024-07-31 ダウングレード B. Riley Securities Buy → Neutral
2024-07-31 ダウングレード Guggenheim Buy → Neutral
2024-05-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-05-10 ダウングレード Stifel Buy → Hold
2024-05-10 ダウングレード TD Cowen Buy → Hold
2024-04-26 開始されました B. Riley Securities Buy
2024-04-09 アップグレード TD Cowen Hold → Buy
2024-03-04 繰り返されました BTIG Research Buy
2024-02-14 ダウングレード H.C. Wainwright Buy → Neutral
2023-12-20 アップグレード Citigroup Neutral → Buy
2023-11-07 アップグレード Guggenheim Neutral → Buy
2023-03-17 ダウングレード Guggenheim Buy → Neutral
2022-11-22 ダウングレード Cowen Outperform → Market Perform
2022-11-14 アップグレード BMO Capital Markets Market Perform → Outperform
2022-07-18 ダウングレード SMBC Nikko Outperform → Neutral
2022-07-11 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-05-04 ダウングレード Guggenheim Buy → Neutral
2022-02-28 アップグレード Citigroup Neutral → Buy
2022-02-11 開始されました BMO Capital Markets Outperform
2022-02-04 開始されました SMBC Nikko Outperform
2021-11-17 再開されました Guggenheim Buy
2021-10-19 開始されました JMP Securities Mkt Outperform
2021-10-15 再開されました BTIG Research Buy
2021-04-26 再開されました Credit Suisse Outperform
2021-03-12 アップグレード Barclays Underweight → Overweight
2020-12-22 再開されました H.C. Wainwright Buy
2020-08-03 ダウングレード Citigroup Buy → Neutral
2020-06-01 アップグレード Guggenheim Neutral → Buy
2020-05-26 繰り返されました H.C. Wainwright Buy
2020-03-04 開始されました Barclays Underweight
2019-12-19 開始されました Cantor Fitzgerald Overweight
2019-12-18 開始されました Cantor Fitzgerald Overweight
2019-11-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2019-11-20 再開されました Guggenheim Neutral
2019-05-03 アップグレード Wedbush Neutral → Outperform
2019-04-12 開始されました Guggenheim Neutral
2019-02-07 アップグレード Citigroup Sell → Buy
2019-02-07 ダウングレード Wedbush Outperform → Neutral
2019-02-06 アップグレード Raymond James Underperform → Mkt Perform
2019-02-04 ダウングレード Citigroup Neutral → Sell
2018-12-10 ダウングレード Raymond James Outperform → Underperform
2018-09-10 再開されました BTIG Research Buy
2018-05-31 開始されました Evercore ISI Outperform
2018-03-05 開始されました H.C. Wainwright Buy
2017-03-31 開始されました Raymond James Outperform
すべてを表示

Macrogenics Inc (MGNX) 最新ニュース

pulisher
10:35 AM

MacroGenics: Whipsaws On Clinical Data, But The Big Picture Is Still Important (MGNX) - Seeking Alpha

10:35 AM
pulisher
08:01 AM

Citizens reiterates MacroGenics stock rating ahead of ESMO data - Investing.com

08:01 AM
pulisher
06:19 AM

Citizens reiterates MacroGenics stock rating ahead of ESMO data By Investing.com - Investing.com Canada

06:19 AM
pulisher
Jul 26, 2026

MacroGenics Inc (MGNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

MacroGenics, Inc. Revenue Breakdown – NASDAQ:MGNX - TradingView

Jul 26, 2026
pulisher
Jul 26, 2026

MGNX|MacroGenics Inc|Price:3.700|Chg%:-0.310 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

MacroGenics Inc (MGNX) Cash Flow - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

MacroGenics, Inc. Revenue Breakdown – DUS:M55 - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

TradingKey - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

MacroGenics slips on trial data for lead asset (MGNX:NASDAQ) - Seeking Alpha

Jul 24, 2026
pulisher
Jul 24, 2026

MacroGenics Inc (MGNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 23, 2026

MacroGenics’ MGC026 meets Phase 1 trial milestone in SCCHN - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

MacroGenics (MGNX) Advances Phase 1 Study of MGC026 - GuruFocus

Jul 23, 2026
pulisher
Jul 23, 2026

MacroGenics’ MGC026 meets trial threshold in head and neck cancer By Investing.com - Investing.com Nigeria

Jul 23, 2026
pulisher
Jul 23, 2026

MacroGenics’ MGC026 meets trial threshold in head and neck cancer - Investing.com

Jul 23, 2026
pulisher
Jul 23, 2026

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 - The Manila Times

Jul 23, 2026
pulisher
Jul 23, 2026

Entera Bio Leads Our Top 3 Penny Stocks To Consider - Sahm

Jul 23, 2026
pulisher
Jul 23, 2026

MGNX stock holds focus as MacroGenics plans and pipeline metrics matter - Ad-hoc-news.de

Jul 23, 2026
pulisher
Jul 20, 2026

MacroGenics (MGNX): Millennium group discloses 3.7% beneficial stake in amended 13G - Stock Titan

Jul 20, 2026
pulisher
Jul 17, 2026

MacroGenics stock gains after FDA priority review as revenue rises and cash runway extends - Ad-hoc-news.de

Jul 17, 2026
pulisher
Jul 17, 2026

MacroGenics Inc (NASDAQ: MGNX) Share Price, MGNX Stock News, MGNX Share Price & Updates - Kalkine

Jul 17, 2026
pulisher
Jul 13, 2026

[144] MACROGENICS INC SEC Filing - Stock Titan

Jul 13, 2026
pulisher
Jul 13, 2026

Form 144 MACROGENICS For: 13 July By Investing.com - Investing.com Nigeria

Jul 13, 2026
pulisher
Jul 10, 2026

MacroGenics (MGNX) Short Interest & Short Float | Updated Jul 2026 - MarketBeat

Jul 10, 2026
pulisher
Jul 09, 2026

MGNX Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pipeline DevelopmentOperating Margin Analysis - dars.gov.et

Jul 09, 2026
pulisher
Jul 08, 2026

MacroGenics, Inc. 8-K SEC Filing July 2026: Company Details, Stock Info, and Key Regulatory Disclosures - Minichart

Jul 08, 2026
pulisher
Jul 08, 2026

MacroGenics (MGNX) Slides Further as Stock Hovers Near Key Support LevelsTime Weighted Price - DonanımHaber

Jul 08, 2026
pulisher
Jul 08, 2026

MacroGenics announces upcoming board change with director resignation - TipRanks

Jul 08, 2026
pulisher
Jul 08, 2026

Karen Ferrante to Resign from MacroGenics' Board Effective Sept 1, 2026 - TradingView

Jul 08, 2026
pulisher
Jul 08, 2026

Board member Karen Ferrante to leave MacroGenics (MGNX) board in September 2026 - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Macrogenics, Inc. Announces Resignation of Karen Ferrante from Director Role, Effective September 1, 2026 - marketscreener.com

Jul 08, 2026
pulisher
Jul 08, 2026

MacroGenics Inc highlights its oncology pipeline as investors track future catalysts - Ad-hoc-news.de

Jul 08, 2026
pulisher
Jul 07, 2026

MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million - Minichart

Jul 07, 2026
pulisher
Jul 07, 2026

MacroGenics Completes Asset Sale, Shifts to R&D Focus - TipRanks

Jul 07, 2026
pulisher
Jul 07, 2026

MacroGenics (NASDAQ: MGNX) nets $110.7M and gain in CDMO sale - Stock Titan

Jul 07, 2026
pulisher
Jul 07, 2026

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Mfg. Ops - Contract Pharma

Jul 07, 2026
pulisher
Jul 07, 2026

Bora Pharmaceuticals completes $122.5M buy of MacroGenics manufacturing operations - megaproject.com

Jul 07, 2026
pulisher
Jul 03, 2026

M55 Forecast — Price Target — Prediction for 2027 - TradingView

Jul 03, 2026
pulisher
Jul 02, 2026

MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Jul 02, 2026
pulisher
Jul 02, 2026

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing OperationsBrand Spur - Brand Spur

Jul 02, 2026
pulisher
Jul 02, 2026

MacroGenics completes sale of manufacturing operations to Bora By Investing.com - Investing.com Australia

Jul 02, 2026
pulisher
Jul 02, 2026

MacroGenics completes sale of manufacturing operations to Bora - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

MacroGenics sells its drug-making operations to Bora for $122.5M - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Bora Pharmaceuticals Completes Acquisition Of Macrogenics' Rockville Manufacturing Operations - Menafn

Jul 02, 2026
pulisher
Jun 30, 2026

Macrogenics | 4: Statement of changes in beneficial ownership of securities-Director O'Brien Federica F. - Moomoo

Jun 30, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS:MGNX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

MacroGenics, Inc.(NasdaqGS: MGNX) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of MacroGenics, Inc. – NASDAQ:MGNX - TradingView

Jun 28, 2026

Macrogenics Inc (MGNX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
大文字化:     |  ボリューム (24 時間):